TY - JOUR
T1 - Six-Year Follow-up of the Norwegian Multicenter Study on Timolol after Myocardial Infarction
AU - Bellin, Eran Y.
AU - Pedersen, Terje R.
PY - 1986/4/17
Y1 - 1986/4/17
N2 - To the Editor: I wish to bring to the attention of your readers a potentially misleading abstract in the study by T.R. Pedersen on the six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction (Oct. 24 issue).* Pedersen et al. state in their abstract: “We conclude that the previously observed early beneficial effect of beta-adrenergic blocking therapy is maintained for at least six years after infarction.” In their careful and informative discussion, however, the authors cautiously state: “In the meantime, the present analysis shows no harmful effect, and possibly a continued benefit, from long-term treatment with…, No extract is available for articles shorter than 400 words.
AB - To the Editor: I wish to bring to the attention of your readers a potentially misleading abstract in the study by T.R. Pedersen on the six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction (Oct. 24 issue).* Pedersen et al. state in their abstract: “We conclude that the previously observed early beneficial effect of beta-adrenergic blocking therapy is maintained for at least six years after infarction.” In their careful and informative discussion, however, the authors cautiously state: “In the meantime, the present analysis shows no harmful effect, and possibly a continued benefit, from long-term treatment with…, No extract is available for articles shorter than 400 words.
UR - http://www.scopus.com/inward/record.url?scp=0022570985&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022570985&partnerID=8YFLogxK
U2 - 10.1056/NEJM198604173141615
DO - 10.1056/NEJM198604173141615
M3 - Letter
C2 - 3515187
AN - SCOPUS:0022570985
SN - 0028-4793
VL - 314
SP - 1052
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 16
ER -